Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report By Product Type (Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils, Intrasaccular Flow Disruptors), By End-User, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 1055 | Published : 2023-04-19 | Pages: 190 | Format: PDF/EXCEL

The Neurovascular Embolization Devices Market Size is valued at 1.39 Billion in 2022 and is predicted to reach 2.37 Billion by the year 2031 at a 6.4 % CAGR during the forecast period for 2023-2031.

Neurovascular Embolization Devices Market

These coils are prescription equipment implanted into the aneurysm sac by a physician to block blood flow and promote thrombosis. Since coil-treated aneurysms may have residual filling or recur, placing the patient at risk for late hemorrhage, follow-up imaging is done when post-procedure is required. Digital Subtraction Angiography (DSA) was traditionally the method used after coiling to imagine aneurysms. However, since improvements in image clarity and usability of MRA, many health care providers can opt to use MRA instead of DSA, so patients are not vulnerable to an embolic stroke or ionizing radiation hazards.

With the help of embolization coils and liquid embolic systems, healthcare companies in the neurovascular embolization devices (neurology) market have successfully laid a solid foundation for treatment options. However, with some health problems, such as wide-neck bifurcated aneurysms, specific therapeutic methods pose particular difficulties. Manufacturers are introducing monotherapy saccular implants to overcome this challenge. Centered on the same principle, healthcare companies are designing Woven EndoBridge (WEB) aneurysm embolization solutions in the neurovascular embolization devices (neurology) industry that resolve the complications associated with coil-assist devices and surgical clippings.

Market Segmentation

The neurovascular embolization devices market is a segment based on product type, end-user, and geography. In terms of product type, the global market is segregated into aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils, and intravascular flow disruptors. The embolization coils product segment is expected to dominate the global neurovascular embolization devices (neurology) during the forecast period. The rapid acceptance and growing demand for embolization coils, since they are one of the oldest recognized embolization instruments, and well-trained interventional radiologists in conducting embolization procedures with these instruments since opposed to others, make them essential for specific embolization procedures.


Based on end-user, the global neurovascular embolization devices market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Globally, the increase in the prevalence of stroke is projected to drive the global market for neurovascular embolization devices (neurology) during the forecast period. About 33 million people globally suffer from stroke, according to WHO, last year. In comparison, in low- and middle-income economies, 70 per cent of stroke and 87% of stroke-related injuries and mortalities exist. In addition, stroke incidence rates in low- and middle-income countries have more than doubled in the last four decades. Stroke is the second-largest cause of mortality and the third-largest cause of disability worldwide. The increase in prevalence and burden of stroke will drive the need for surgery, which is expected to accelerate the growth of the global market for neurovascular embolization devices (neurology) in the coming years.


Based on geography, the global neurovascular embolization devices market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, over the forecast period, North America is expected to account for a leading share of the global market for neurovascular embolization devices (neurology), owing to a rise in occurrence levels of neurovascular diseases, especially brain aneurysm, in the United States. According to the Brain Aneurysm Foundation, the brain aneurysm has been unbroken by 1 in 50 people, or 6 million individuals in the U.S. Every year around 30,000 people in the country suffer from rupture of cerebral aneurysm. That, in turn, is expected to drive the country’s demand for neurovascular embolization devices (neurology).


The Asia Pacific demand for neurovascular embolization devices (neurology) is expected to expand at a fast pace in the near future. Given the high prevalence of cerebrovascular disorders, unhealthy lifestyle choices such as smoking, bad diets, and high incidence of diabetes and hypertension, India and China are projected to be attractive markets during the forecast period,

Competitive Landscape

Some Major Key Players In The Neurovascular Embolization Devices Market:

  • Acandis GmBH,
  • Braun,
  • BALT Extrusion,
  • Emboflu,
  • Stryker,
  • Johnson & Johnson (Cerenovus),
  • KLS Martin,
  • Medtronic Plc,
  • Mizuho Medical,
  • Peter Lazic GmBH,
  • Phenox GmBH,
  • Spartan Micro,
  • Terumo Corporation (MicroVention)

 

Neurovascular Embolization Devices Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 139 Billion

Revenue Forecast In 2031

USD 2.37 Billion

Growth Rate CAGR

CAGR of 6.4 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Acandis GmBH, B. Braun, BALT Extrusion, Emboflu, Stryker, Johnson & Johnson (Cerenovus), KLS Martin, Medtronic Plc, Mizuho Medical, Peter Lazic GmBH, Phenox GmBH, Spartan Micro, Terumo Corporation (MicroVention) among others.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Neurovascular Embolization Devices Market Snapshot

Chapter 4. Global Neurovascular Embolization Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers and Challenges

4.3. Trends

4.4. Industry Analysis – Porter’s Five Forces Analysis

4.5. Competitive Landscape & Market Share Analysis

4.6. Incidence and Prevalence by Indication in Key Countries

Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis

5.1. Product Type & Market Share, 2016 & 2026

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2017 to 2027 for the following Product:

5.2.1. Aneurysm Clips

5.2.2. Liquid Embolic Systems

5.2.3. Flow Diversion Stents

5.2.4. Embolization Coils

5.2.5. Intrasaccular Flow Disruptors

Chapter 6. Market Segmentation 1: Indication Estimates & Trend Analysis

6.1. Indication Type & Market Share, 2016 & 2026

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2017 to 2027 for the following Indication:

6.2.1. Brain Aneurysm

6.2.2. Arteriovenous Malformation (AVM)

6.2.3. Others

Chapter 7. Market Segmentation 1: Treatment Scope Estimates & Trend Analysis

7.1. Treatment Type & Market Share, 2016 & 2026

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2017 to 2027 for the following Treatment:

7.2.1. Ischemic Stroke Solution

7.2.2. Hemorrhagic Stroke Solution

Chapter 8. Neurovascular Embolization Devices Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product, 2017-2027

8.1.2. North America Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2017-2027

8.1.2.1. U.S.

8.1.2.2. Canada

8.2. Europe

8.2.1. Europe Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by Product, 2017-2027

8.2.2. Europe Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2017-2027

8.2.2.1. Germany

8.2.2.2. Poland

8.2.2.3. France

8.2.2.4. Italy

8.2.2.5. Spain

8.2.2.6. UK

8.2.2.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by Product, 2017-2027

8.3.2. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2017-2027

8.3.2.1. China

8.3.2.2. India

8.3.2.3. Japan

8.3.2.4. Australia

8.3.2.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by Product, 2017-2027

8.4.2. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2017-2027

8.4.2.1. Brazil

8.4.2.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Neurovascular Embolization Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2017-2027

8.5.1.1. South Africa

8.5.1.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Acandis GmBH

9.2.2. B. Braun

9.2.3. BALT Extrusion

9.2.4. Emboflu

9.2.5. Stryker

9.2.6. Johnson & Johnson (Cerenovus)

9.2.7. KLS Martin

9.2.8. Medtronic Plc

9.2.9. Mizuho Medical

9.2.10. Peter Lazic GmBH

9.2.11. Phenox GmBH

9.2.12. Spartan Micro

9.2.13. Terumo Corporation (MicroVention)

Global Neurovascular Embolization Devices Market Segmentation

 

Global Neurovascular Embolization Devices Market Outlook (Value (US$ Mn) & Volume (no. of units), 2019 - 2030) By Product Type

  • Aneurysm Clips
  • Liquid Embolic Systems
  • Flow Diversion Stents
  • Embolization Coils
  • Intrasaccular Flow Disruptors

Global Neurovascular Embolization Devices Market Outlook (Value (US$ Mn), 2019 - 2030) By End-Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

 Neurovascular Embolization Devices Market

Global Neurovascular Embolization Devices Market Outlook (Value (US$ Mn) & Volume (no. of units), 2019 - 2030) By Region

  • Europe
    • Germany
    • Poland
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Neurovascular Embolization Devices Market Size?

The Neurovascular Embolization Devices Market Size is valued at 1.39 Billion in 2022 and is predicted to reach 2.37 Billion by the year 2031 at a 6.4

Acandis GmBH, B. Braun, BALT Extrusion, Emboflu, Stryker, Johnson & Johnson (Cerenovus), KLS Martin, Medtronic Plc, Mizuho Medical, Peter Lazic GmBH,

Our Clients

Media Citations

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4182
$10000
$1200
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals

Review Request

We’ll review your request & send a personalized quote for cost and time needed

Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..